Literature DB >> 15613471

Functional overexpression of gamma-secretase reveals protease-independent trafficking functions and a critical role of lipids for protease activity.

Jonathan D J Wrigley1, Irina Schurov, Emma J Nunn, Agnes C L Martin, Earl E Clarke, Semantha Ellis, Timothy P Bonnert, Mark S Shearman, Dirk Beher.   

Abstract

Presenilins appear to form the active center of gamma-secretase but require the presence of the integral membrane proteins nicastrin, anterior pharynx defective 1, and presenilin enhancer 2 for catalytic function. We have simultaneously overexpressed all of these polypeptides, and we demonstrate functional assembly of the enzyme complex, a substantial increase in enzyme activity, and binding of all components to a transition state analogue gamma-secretase inhibitor. Co-localization of all components can be observed in the Golgi compartment, and further trafficking of the individual constituents seems to be dependent on functional assembly. Apart from its catalytic function, gamma-secretase appears to play a role in the trafficking of the beta-amyloid precursor protein, which was changed upon reconstitution of the enzyme but unaffected by pharmacological inhibition. Because the relative molecular mass and stoichiometry of the active enzyme complex remain elusive, we performed size exclusion chromatography of solubilized gamma-secretase, which yielded evidence of a tetrameric form of the complex, yet almost completely abolished enzyme activity. Gamma-secretase activity was reconstituted upon addition of an independent size exclusion chromatography fraction of lower molecular mass and nonproteinaceous nature, which could be replaced by a brain lipid extract. The same treatment was able to restore enzyme activity after immunoaffinity purification of the gamma-secretase complex, demonstrating that lipids play a key role in preserving the catalytic activity of this protease. Furthermore, these data show that it is important to discriminate between intact, inactive gamma-secretase complexes and the active form of the enzyme, indicating the care that must be taken in the study of gamma-secretase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15613471     DOI: 10.1074/jbc.M413086200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  In vivo reconstitution of gamma-secretase in Drosophila results in substrate specificity.

Authors:  Denise Stempfle; Ritu Kanwar; Alexander Loewer; Mark E Fortini; Gunter Merdes
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

Review 2.  The study of Golgi apparatus in Alzheimer's disease.

Authors:  Zhiping Hu; Liuwang Zeng; Zhiling Huang; Jie Zhang; Ting Li
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

3.  Generation of Alzheimer disease-associated amyloid β42/43 peptide by γ-secretase can be inhibited directly by modulation of membrane thickness.

Authors:  Edith Winkler; Frits Kamp; Johannes Scheuring; Amelie Ebke; Akio Fukumori; Harald Steiner
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

4.  A protease-independent function for SPPL3 in NFAT activation.

Authors:  Stefanie L Makowski; Zhaoquan Wang; Joel L Pomerantz
Journal:  Mol Cell Biol       Date:  2014-11-10       Impact factor: 4.272

Review 5.  The Role of Presenilin in Protein Trafficking and Degradation-Implications for Metal Homeostasis.

Authors:  M A Greenough
Journal:  J Mol Neurosci       Date:  2016-08-25       Impact factor: 3.444

Review 6.  Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies.

Authors:  Geneviève Evin; Marijke Fleur Sernee; Colin L Masters
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 7.  Notch, lipids, and endothelial cells.

Authors:  Anaïs Briot; Anne Bouloumié; M Luisa Iruela-Arispe
Journal:  Curr Opin Lipidol       Date:  2016-10       Impact factor: 4.776

Review 8.  BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis.

Authors:  Neville Marks; Martin J Berg
Journal:  Neurochem Res       Date:  2009-09-17       Impact factor: 3.996

9.  Competition between homodimerization and cholesterol binding to the C99 domain of the amyloid precursor protein.

Authors:  Yuanli Song; Eric J Hustedt; Suzanne Brandon; Charles R Sanders
Journal:  Biochemistry       Date:  2013-07-18       Impact factor: 3.162

10.  Direct and potent regulation of gamma-secretase by its lipid microenvironment.

Authors:  Pamela Osenkowski; Wenjuan Ye; Rong Wang; Michael S Wolfe; Dennis J Selkoe
Journal:  J Biol Chem       Date:  2008-06-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.